SK
Sudheer Kumar Pasula
About Sudheer Kumar Pasula
Sudheer Kumar Pasula has 6 years in corporate governance. Holds Designated Partner role. Currently with 2 companies, including Wewin Technologies Llp and Singularity Health Informatics Llp. Formerly with 2 companies, such as Rebus Research Financial Services Private Limited. Engaged in Technology, Healthcare and more. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Wewin Technologies Llp
AAS-4897
|
Designated Partner | 26 May 2020 | 2020 | Active |
Aramane Technologies Llp
ACD-4765
|
Designated Partner | 17 Oct 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Rebus Research Financial Services Private Limited
U65990MH2020PTC349416
|
Director | 04 Nov 2020 | 2020 | Active |
Singularity Health Informatics Llp
ACE-1289
|
Designated Partner | 28 Nov 2023 | 2023 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudheer Kumar Pasula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudheer Kumar Pasula
Sudheer Kumar Pasula has 6 years in corporate governance. Holds Designated Partner role. Currently with 2 companies, including Wewin Technologies Llp and Singularity Health Informatics Llp. Formerly with 2 companies, such as Rebus Research Financial Services Private Limited. Engaged in Technology, Healthcare and more. Contributes to corporate operations.
Sudheer Kumar Pasula is associated with 2 companies as Designated Partner.
Sudheer Kumar Pasula has expertise in Technology, Healthcare and other sectors.
Sudheer Kumar Pasula has 6 years in corporate governance.